Correction to: Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children.

However, the Original article has been updated with the Open Access under Commercial License.

Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children.

Objectives: The objectives of this study were to investigate the population pharmacokinetics of posaconazole in immunocompromised children, evaluate the influence of patient characteristics on posaconazole exposure and perform simulations to recommend optimal starting doses.

Methods: Posaconazole plasma concentrations from paediatric patients undergoing therapeutic drug monitoring were extracted from a tertiary paediatric hospital database. These were merged with covariates collected from electronic sources and case-note reviews.